Literature DB >> 22351514

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.

Patricia A Ganz1, John M Barry, Wylie Burke, Nananda F Col, Phaedra S Corso, Everett Dodson, M Elizabeth Hammond, Barry A Kogan, Charles F Lynch, Lee Newcomer, Eric J Seifter, Janet A Tooze, Kasisomayajula Viswanath, Hunter Wessells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22351514      PMCID： PMC4774889          DOI： 10.7326/0003-4819-156-8-201204170-00401

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  74 in total

1.  Prostate cancer: a new look at prostate cancer treatment complications.

Authors:  Matthew R Cooperberg
Journal:  Nat Rev Clin Oncol       Date:  2014-04-01       Impact factor: 66.675

2.  Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer.

Authors:  M D Galsky; W Xie; M Nakabayashi; R W Ross; F M Fennessy; C M Tempany; T K Choueiri; K Khine; P W Kantoff; M-E Taplin; W K Oh
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-05-28       Impact factor: 5.554

3.  Expected population impacts of discontinued prostate-specific antigen screening.

Authors:  Roman Gulati; Alex Tsodikov; Ruth Etzioni; Rachel A Hunter-Merrill; John L Gore; Angela B Mariotto; Matthew R Cooperberg
Journal:  Cancer       Date:  2014-07-25       Impact factor: 6.860

4.  Physician variation in management of low-risk prostate cancer: a population-based cohort study.

Authors:  Karen E Hoffman; Jiangong Niu; Yu Shen; Jing Jiang; John W Davis; Jeri Kim; Deborah A Kuban; George H Perkins; Jay B Shah; Grace L Smith; Robert J Volk; Thomas A Buchholz; Sharon H Giordano; Benjamin D Smith
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

Review 5.  Heterogeneity in active surveillance protocols worldwide.

Authors:  Stacy Loeb; H Ballentine Carter; Mark Schwartz; Angela Fagerlin; R Scott Braithwaite; Herbert Lepor
Journal:  Rev Urol       Date:  2014

Review 6.  Organ-confined prostate cancer: are we moving towards more or less radical surgical intervention?

Authors:  Daniel J Stevens; Naomi L Sharma; Ashutosh K Tewari; Roger Kirby; Prasanna Sooriakumaran
Journal:  Curr Urol Rep       Date:  2015-05       Impact factor: 3.092

7.  Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.

Authors:  Tae Heon Kim; Jae Yong Jeong; Sin Woo Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

8.  Commentary on the State-of-the-Science Conference on the role of active surveillance in the management of men with localized prostate cancer.

Authors:  Ingrid J Hall; Lisa C Richardson
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

9.  Gleason score 6 adenocarcinoma: should it be labeled as cancer?

Authors:  H Ballentine Carter; Alan W Partin; Patrick C Walsh; Bruce J Trock; Robert W Veltri; William G Nelson; Donald S Coffey; Eric A Singer; Jonathan I Epstein
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

10.  Five-year nationwide follow-up study of active surveillance for prostate cancer.

Authors:  Stacy Loeb; Yasin Folkvaljon; Danil V Makarov; Ola Bratt; Anna Bill-Axelson; Pär Stattin
Journal:  Eur Urol       Date:  2014-06-30       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.